{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:07:23Z","timestamp":1720616843810},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1378\/chest.103.4_supplement.418s","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T09:23:22Z","timestamp":1223717002000},"page":"418S-422S","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Incorporation of Radiotherapy Fractionation in the Combined-Modality Treatment of Limited Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"103","author":[{"given":"Andrew T.","family":"Turrisi, III","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.103.4_Supplement.418S_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0360-3016(87)91202-8","article-title":"Locoregional failure rate in relation with radiation dose in combined modality approach of multi-agent chemotherapy and radiotherapy for limited small cell lung carcinoma [abstract].","volume":"13","author":"Choi NC, Carey","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM198704093161504","article-title":"Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung.","volume":"316","author":"Perry","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib3","series-title":"Frontiers of radiation therapy and oncology.","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000392812","article-title":"Radiation pathology and the clinical response of the lung and esophagus.","author":"Phillips","year":"1972"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib4","first-page":"119","article-title":"Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and site of regional pulmonary function in predicting postradiotherapy lung (unction.","volume":"2","author":"Choi","year":"1985","journal-title":"Cancer Treat Symp (NCI Monograph)"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0360-3016(88)90350-1","article-title":"Prospective prediction of postradiation therapy lung function using quantitative lung scans and pulmonary function testing.","volume":"15","author":"Rubenstein","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0360-3016(90)90231-8","article-title":"Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus.","volume":"19","author":"Saunders","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.1990.8.9.1543","volume":"8","author":"Cox","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib8","first-page":"359","article-title":"The relationship of biological effect to dose-time-fractionation factors in radiotherapy.","volume":"4","author":"Ellis","year":"1968","journal-title":"Curr Top Radiat Res"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0360-3016(80)90175-3","article-title":"Therapeutic radiation and brain injury.","volume":"6","author":"Sheline","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0360-3016(85)90369-4","article-title":"The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.","volume":"11","author":"Lelieveld","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0360-3016(90)90217-8","article-title":"Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma.","volume":"19","author":"Arriagada","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.1992.10.3.447","article-title":"Competing events determining relapse-free survival in limited small-cell lung carcinoma.","volume":"10","author":"Arriagada","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib13","first-page":"243","article-title":"The importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited stage small cell lung cancer (LSCLC) [abstract 831].","volume":"10","author":"Murray","year":"1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1200\/JCO.1988.6.3.451","article-title":"Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin and vincristine in limited small-cell lung cancer.","volume":"6","author":"Einhorn","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.1990.8.5.892","article-title":"Concurrent chemotherapy\/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group study.","volume":"8","author":"McCracken","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib16","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/1097-0142(19851215)56:12<2771::AID-CNCR2820561209>3.0.CO;2-A","article-title":"Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung.","volume":"56","author":"Shank","year":"1985","journal-title":"Cancer"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib17","first-page":"887","article-title":"Limited small cell lung cancer (LSCLC): concurrent BID thoracic radiotherapy (TRT) with platinum-etoposide (PE): an ECOG study [abstract].","volume":"9","author":"Turrisi","year":"1990","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib18","first-page":"243","article-title":"Alternating chemotherapy (CT) and thoracic radiotherapy (TRI) in limited small cell lung cancer (LSCLC): a test of the Looney hypothesis [abstract].","volume":"10","author":"Johnson","year":"1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-5002(91)91938-8","article-title":"Accelerated hyperfractionated split-course thoracic radiotherapy (AHSCTRT) and infusion cisplatin based chemotherapy (CT) for small cell lung cancer (SCLC) [abstract].","volume":"7","author":"Frytak","year":"1991","journal-title":"Lung Cancer"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib20","first-page":"292","article-title":"Long term results of platinum etoposide (PE) + twice-daily (BID) thoracic radiotherapy (TRT) for limited small-cell lung cancer (LSCLC): results of 32 patients with 48 month minimum F\/U [abstract].","volume":"11","author":"Turrisi","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib21","first-page":"240","article-title":"Limited (LTD) stage small cell lung cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide\/cisplatin (VP\/PT) followed by chemotherapy (CT) selected by in vitro drug sensitivity testing (DST) [abstract].","volume":"10","author":"Johnson","year":"1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib22","first-page":"2806","article-title":"In vitro radiation and chemosensitivity of established cell lines of human small cell lung cancer and its large cell variants.","volume":"43","author":"Carney","year":"1983","journal-title":"Cancer Res"},{"key":"10.1378\/chest.103.4_Supplement.418S_bib23","first-page":"288","article-title":"Meta-analysis of randomized trials evaluating the role of thoracic radiotherapy (TRT) in limited-stage (LD) small cell lung cancer (SCLC) [abstract].","volume":"11","author":"Johnson","year":"1992","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215371166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215371166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T01:21:21Z","timestamp":1545700881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215371166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["S0012369215371166"],"URL":"https:\/\/doi.org\/10.1378\/chest.103.4_supplement.418s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}